Johnson & Johnson Newsroom

Johnson & Johnson Analyst Ratings

BenzingaJul 23 05:36 ET

Daiwa Downgrades Johnson & Johnson to Neutral From Outperform, Adjusts Price Target to $150 From $160

MT NewswiresJul 23 05:25 ET

Guggenheim Adjusts Johnson & Johnson's Price Target to $156 From $160, Maintains Neutral Rating

MT NewswiresJul 22 07:55 ET

Buy Rating Affirmed for Johnson & Johnson on Strong Growth and Strategic Acquisitions

TipRanksJul 22 01:45 ET

Johnson & Johnson Analyst Ratings

BenzingaJul 19 13:04 ET

HSBC Adjusts Price Target on Johnson & Johnson to $174 From $170, Maintains Buy Rating

MT NewswiresJul 19 08:47 ET

RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target

BenzingaJul 18 10:40 ET

Johnson & Johnson (JNJ) Gets a Buy From RBC Capital

TipRanksJul 18 06:41 ET

Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $167, Maintains Equalweight Rating

MT NewswiresJul 18 05:38 ET

Johnson & Johnson Analyst Ratings

BenzingaJul 18 05:28 ET

Stifel Raises Johnson & Johnson's Price Target to $160 From $155

MT NewswiresJul 17 14:54 ET

Hold Rating Maintained Amid Johnson & Johnson Acquisition and Foreign Exchange Concerns

TipRanksJul 15 05:45 ET

Stifel Nicolaus Remains a Hold on Johnson & Johnson (JNJ)

TipRanksJul 12 07:09 ET

Johnson & Johnson Analyst Ratings

BenzingaJul 1 09:32 ET

Johnson & Johnson Analyst Ratings

BenzingaJun 25 10:54 ET

Johnson & Johnson Analyst Ratings

BenzingaJun 20 13:02 ET

Johnson & Johnson Analyst Ratings

BenzingaJun 17 09:05 ET

Halozyme Downgraded at Piper Sandler Despite Guidance Raise

Seeking AlphaJun 7 09:16 ET

Citigroup Adjusts Price Target on Johnson & Johnson to $180 From $185, Keeps Buy Rating

MT NewswiresJun 6 05:17 ET

Johnson & Johnson Analyst Ratings

BenzingaJun 4 09:57 ET